Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumors

Waramit S., Suwan K., Küçük A., Benjathummarak S., Cencioni MT., Ashfield R., Gay L., Draper SJ., Hajitou A.